Philip Morris International Inc.

PM

PM operates in the cigarettes industry, primarily manufacturing and selling tobacco products.
It is a global leader in the sector, known for its strong brand portfolio and extensive international market presence.

$186.83 -0.67 (-0.36%)

Updated: February 27, 2026, 16:00 EST

Analyzed by Rockflow Bobby Quantitative Model ✓ Updated Daily

Investment Opinion: Should I buy PM Today?

Analysis of Philip Morris International (PM)

Technical Analysis PM has delivered impressive short-term gains with remarkably low volatility, a rare and attractive combination. While the stock sits near its 52-week high—indicating potential overbought conditions—its strong relative momentum suggests the uptrend may still have underlying support. However, investors should be cautious of a near-term consolidation given the sharp recent run-up.

Fundamentals PM maintains solid profitability metrics, including a robust gross margin and adequate interest coverage. Nevertheless, operational challenges are evident, including declining revenue, negative return on equity, and an extended cash conversion cycle—signaling inefficiency in asset and working capital management. The negative equity position adds a layer of financial risk despite the absence of immediate liquidity concerns.

Valuation The stock appears richly valued, with a forward P/E above its trailing figure and an extremely high EV/EBITDA multiple. The negative PEG ratio further clouds the growth outlook, implying the market may be overestimating future earnings potential. Even without direct peer comparisons, these metrics suggest premium pricing relative to fundamentals.

Risk Risk is mitigated by PM’s low beta and negligible short interest, reflecting investor confidence and lower volatility. However, the substantial maximum drawdown reminds investors that significant declines are possible. Structural risks, such as regulatory pressures and shifting consumer habits, remain persistent long-term concerns.

---

Investment Recommendation

PM demonstrates strong technical momentum and respectable profitability, but these positives are offset by operational inefficiencies and a demanding valuation. The stock’s low volatility and defensive characteristics offer some appeal for risk-averse investors, yet upside may be limited given its elevated price levels. A cautious approach is warranted; existing holders might maintain positions, but new buyers should wait for a more attractive entry point or clearer signs of operational improvement.

CTA Banner

PM 12-Month Price Forecast

RockFlow Model Forecast: Three Scenarios for 2026

Based on the comprehensive analysis, here is a 12-month outlook for Philip Morris International (PM):

12-Month Outlook for PM

PM's outlook is clouded by operational headwinds despite its strong technical momentum. The key catalyst for the stock will be demonstrating tangible progress in its smoke-free product portfolio (like IQOS) to drive revenue growth and improve asset efficiency, justifying its premium valuation. Major risks include the persistence of declining revenue, negative equity, and the high likelihood of a price correction given its stretched valuation near 52-week highs. Given the lack of a specific analyst target and the conflicting signals, a cautious target range of $170-$200 is plausible, reflecting the potential for consolidation or a pullback from current levels before a clearer fundamental picture emerges.

Wall Street Consensus

Most Wall Street analysts are optimistic about Philip Morris International Inc.'s 12-month outlook, with consensus target around $186.83, indicating expected upside potential.

Average Target
$186.83
18 analysts
Implied Upside
+0%
vs. current price
Analyst Count
18
covering this stock
Price Range
$149 - $243
Analyst target range
Buy Buy
13 (72%)
Hold Hold
4 (22%)
Sell Sell
1 (6%)

Bulls vs Bears: PM Investment Factors

Overall, PM has investment potential but also faces challenges. Here are key factors to weigh before investing.

Bullish Bullish
  • Reliable Investment Performance: PM has been a consistently well-performing stock for investors historically.
  • Resilient Dividend: The company continues to offer a strong and attractive dividend to shareholders.
  • Anticipated FDA Catalysts: Potential upcoming FDA decisions could act as positive catalysts for the stock.
Bearish Bearish
  • Institutional Selling Pressure: Dakota Wealth Management significantly reduced its holdings in PM.
  • Market Volatility Exposure: General market downturns and tech stock pressures can impact PM.
  • Sin Stock Stigma: Being a cigarette company limits its appeal to certain ESG-focused investors.
Reward Banner

PM Technical Analysis

PM has demonstrated strong outperformance with significant 3-month gains while exhibiting low volatility characteristics. The stock shows robust momentum despite approaching its 52-week high, supported by substantial relative strength against the market.

Short-term performance has been exceptional, with PM gaining 5.13% over one month and 20.95% over three months, significantly outperforming the market by 17.24% during the latter period. This strong momentum is particularly notable given the stock's low beta of 0.409, indicating these gains were achieved with below-market volatility.

Currently trading 30.5% above its 52-week low and just 1.9% below its 52-week high of $191.30, PM appears to be in overbought territory. The minimal distance from its yearly peak, combined with the recent steep ascent, suggests limited near-term upside potential despite the stock's strong fundamental performance.

📊 Beta
0.41
0.41x market volatility
📉 Max Drawdown
-22.0%
Largest decline past year
📈 52-Week Range
$142-$191
Price range past year
💹 Annual Return
+20.3%
Cumulative gain past year
Period PM Return S&P 500
1m +4.6% -1.4%
3m +20.4% +4.1%
6m +8.1% +7.5%
1y +20.3% +15.4%
ytd +16.6% +0.4%

PM Fundamental Analysis

Revenue & Profitability: PM demonstrated mixed profitability performance in Q4 2025, with a solid gross profit margin of 65.4% but a sequential decline in operating margin to 33.0% from 39.3% in Q3. The net income ratio of 22.3% reflects effective cost management despite revenue decreasing to $10.4 billion from $10.8 billion in the previous quarter.

Financial Health: The company shows concerning liquidity with a current ratio below 1.0 and a negative equity position indicated by the negative debt-to-equity ratio, suggesting potential financial strain. However, the interest coverage ratio of 10.5 indicates sufficient earnings to service debt obligations, providing some stability.

Operational Efficiency: PM faces efficiency challenges with a negative return on equity (-23.1%) and low asset turnover of 0.15, indicating suboptimal utilization of assets. The extended cash conversion cycle of 228 days, driven by high inventory days outstanding, suggests working capital management could be improved.

Quarterly Revenue
$10.4B
2025-12
Revenue YoY Growth
+4.5%
YoY Comparison
Gross Margin
65.6%
Latest Quarter
Free Cash Flow
$8.3B
Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

RockFlow Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

Try Now & Get Tesla Stock Reward

Valuation Analysis: Is PM Overvalued?

Based on the available metrics, PM appears modestly overvalued. The forward P/E of 26.1 exceeds the trailing P/E of 24.6, indicating anticipated earnings growth, but the significantly negative PEG ratio of -0.94 (typically driven by negative expected growth) introduces a major cautionary signal. Furthermore, an EV/EBITDA of 76.3 is exceptionally high, suggesting the market is pricing in a substantial premium for its cash flows relative to its enterprise value.

A peer comparison is not feasible as industry average data is unavailable. This absence of context makes it difficult to normalize PM's valuation multiples; however, the extreme values of its EV/EBITDA and negative PB and PEG ratios are concerning on an absolute basis. These metrics suggest the stock's valuation relies heavily on factors not captured by standard profitability or growth measures.

PE
24.6x
Latest Quarter
vs. Historical
Near High
5-Year PE Range -81×-26×
vs. Industry Avg
N/A
Industry PE ~N/A×
EV/EBITDA
76.3x
Enterprise Value Multiple

Investment Risk Disclosure

The stock exhibits low volatility risk, as indicated by a Beta of 0.409, suggesting it is significantly less volatile than the broader market. However, investors should note the 1-year maximum drawdown of -21.96%, which represents a meaningful decline from peak to trough and highlights potential downside exposure despite the low beta reading.

PM faces minimal short-term speculative pressure, evidenced by the nonexistent short interest, implying strong market confidence in its near-term prospects. Liquidity risk also appears low, given the substantial market capitalization and trading volume typical of major tobacco stocks, though the company remains exposed to fundamental risks like regulatory changes and declining smoking rates.

FAQs

Is PM a good stock to buy?

Neutral to moderately bearish. PM's strong technical momentum and positive analyst sentiment are offset by concerning valuation metrics (notably negative PEG and extremely high EV/EBITDA) and mixed fundamentals like a negative ROE and weak liquidity. Given its overbought state near its 52-week high, it is less attractive for new purchases at this level. This stock is more suitable for existing, income-focused shareholders tolerant of industry-specific risks, rather than new value or growth investors.

Is PM stock overvalued or undervalued?

Based on the valuation metrics provided, PM appears clearly overvalued. Its Forward P/E of 26.1 and exceptionally high EV/EBITDA of 76.3 suggest the market is pricing in a substantial premium. This is difficult to justify given the company's negative ROE (-23.1%), negative P/B ratio, and negative PEG ratio, which signal serious issues with profitability and expected growth. The high valuation multiples are fundamentally disconnected from the company's weak financial health and operational efficiency.

What are the main risks of holding PM?

Based on the provided information, here are the key risks of holding Philip Morris International (PM) stock, ordered by importance:

1. Financial Health Risk: The company's negative equity position and current ratio below 1.0 indicate potential balance sheet strain and vulnerability to unforeseen financial pressures. 2. Industry & Regulatory Risk: The company remains fundamentally exposed to long-term threats from global regulatory changes and declining smoking rates, which threaten its core business model. 3. Valuation & Momentum Risk: The stock's proximity to its 52-week high after a steep price ascent suggests it may be overbought, presenting a risk of a near-term price correction despite strong momentum. 4. Operational Efficiency Risk: A negative Return on Equity and an excessively long cash conversion cycle point to challenges in profitably utilizing shareholder capital and managing working inventory.

What is the price forecast for PM in 2026?

Based on the provided analysis, my forecast for Philip Morris International (PM) stock through 2026 is cautious, with its success heavily dependent on the execution of its smoke-free transition.

My projected target price range for 2026 is $165 to $220, with a base case of $185 reflecting near-term consolidation and a bull case requiring flawless execution. The key growth drivers are the successful scaling of the IQOS platform and improved operational efficiency to address the negative equity and asset turnover issues. The main assumptions are that the company can stabilize revenues and demonstrate tangible progress in its strategic shift, but the forecast carries high uncertainty due to the persistent operational headwinds and stretched valuation, making the stock highly sensitive to quarterly execution.